Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes

Cited in:

CrossRef

This article has been cited by:

1. 1
   Matilde Y. Follo, Sandra Marmiroli, Irene Faenza, Roberta Fiume, Giulia Ramazzotti, Alberto M. Martelli, Pietro Gobbi, James A. McCubrey, Carlo Finelli, Francesco A. Manzoli, Lucio Cocco, Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS, Advances in Biological Regulation, 2013, 53, 1, 2

   CrossRef

2. 2
   Pasquale Niscola, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Luca Cupelli, Gianfranco Catalano, Alessio Perrotti, Paolo Fabritiis, Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes, Supportive Care in Cancer, 2013,

   CrossRef

3. 3
   Jayshree Shah, Sandra E. Kurtin, Louise Arnold, Petra Lindroos-Kolqvist, Sara Tinsley, Management of Transfusion-Related Iron Overload in Patients With Myelodysplastic Syndromes, Clinical Journal of Oncology Nursing, 2012, 16, 0, 37

   CrossRef

4. 4
   Matilde Y. Follo, Irene Faenza, Roberta Fiume, Giulia Ramazzotti, James A. McCubrey, Alberto M. Martelli, Francesco A. Manzoli, Lucio Cocco, Revisiting nuclear phospholipase C signalling in MDS, Advances in Biological Regulation, 2012, 52, 1, 2

   CrossRef

5. 5
   Mary Laudon Thomas, The Impact of Myelodysplastic Syndromes on Quality of Life: Lessons Learned from 70 Voices, The Journal of Supportive Oncology, 2012, 10, 1, 37

   CrossRef

6. 6
   Michel Delforge, Dominik Selleslag, Agnès Triffet, Philippe Mineur, Greet Bries, Carlos Graux, Fabienne Trullemans, Karen MacDonald, Ivo Abraham, Wim Pluymers, Christophe Ravoet, Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes, Annals of Hematology, 2011, 90, 6, 655

   CrossRef

7. 7
   Roberto Guariglia, Maria Carmen Martorelli, Oreste Villani, Giuseppe Pietrantuono, Giovanna Mansueto, Fiorella D’Auria, Vitina Grieco, Gabriella Bianchino, Rosa Lerose, Giovanni Battista Bochicchio, Pellegrino Musto, Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief review, Leukemia Research, 2011, 35, 5, 566

   CrossRef

8. 8
   M. Dicato, L. Plawny, M. Diederich, Anemia in cancer, Annals of Oncology, 2010, 21, Supplement 7, vii167

   CrossRef

9. 9
   Farshid Dayyani, Anthony P. Conley, Sara S. Strom, William Stevenson, Jorge E. Cortes, Gautam Borthakur, Stefan Faderl, Susan O'Brien, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero, Cause of death in patients with lower-risk myelodysplastic syndrome, Cancer, 2010, 116, 9

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(212K)
   • References
10. 10
    Sophie Park, Charikleia Kelaidi, Rosa Sapena, Dominique Vassilieff, Odile Beyne-Rauzy, Valérie Coiteux, Norbert Vey, Christophe Ravoet, Stéphane Cheze, Christian Rose, Laurence Legros, Aspasia Stamatoullas, Martine Escoffre-Barbe, Agnès Guerci, Marie-Pierre Chaury, Pierre Fenaux, François Dreyfus, Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: A retrospective analysis on 112 patients, Leukemia Research, 2010, 34, 11, 1430

    CrossRef

11. 11
    D. Schrijvers, H. De Samblanx, F. Roila, Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use, Annals of Oncology, 2010, 21, Supplement 5, v244

    CrossRef

12. 12
    Lucio Cocco, Matilde Y. Follo, Irene Faenza, Anna Maria Billi, Giulia Ramazzotti, Alberto M. Martelli, Lucia Manzoli, George Weber, Inositide signaling in the nucleus: From physiology to pathology, Advances in Enzyme Regulation, 2010, 50, 1, 2

    CrossRef

13. 13
    Matilde Y. Follo, Sara Mongiorgi, Carlo Finelli, Cristina Clissa, Giulia Ramazzotti, Roberta Fiume, Irene Faenza, Lucia Manzoli, Alberto M. Martelli, Lucio Cocco, Nuclear inositide signaling in myelodysplastic syndromes, Journal of Cellular Biochemistry, 2010, 109, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(201K)
    • References
14. 14
    Alexandra Göbel, Beate Lubrich, Supportive Therapie bei Myelodysplastischem Syndrom (MDS). Unverzichtbare Säule im multimodalen Behandlungskonzept, Pharmazie in unserer Zeit, 2010, 39, 3

    Direct Link:

    • Abstract
    • PDF(409K)
    • References
15. 15
    Cédric Rafat, Fadi Fakhouri, Jean-Antoine Ribeil, Richard Delarue, Moglie Le Quintrec, Fanconi Syndrome Due to Deferasirox, American Journal of Kidney Diseases, 2009, 54, 5, 931

    CrossRef

16. 16
    Lisa Chodirker, Richard A Wells, Iron overload in myelodysplastic syndromes, Expert Review of Hematology, 2009, 2, 3, 215

    CrossRef

17. 17
    Fredric M. Pieracci, Peter Henderson, John Rocco Macmillan Rodney, Daniel N. Holena, Alicia Genisca, Ivan Ip, Steven Benkert, Lynn J. Hydo, Soumitra R. Eachempati, Jian Shou, Philip S. Barie, Randomized, Double-Blind, Placebo-Controlled Trial of Effects of Enteral Iron Supplementation on Anemia and Risk of Infection during Surgical Critical Illness, Surgical Infections, 2009, 10, 1, 9

    CrossRef

18. 18
    WY Au, WWM Lam, WWC Chu, S Tam, WK Wong, H Chan, MF Law, HSY Liu, R Liang, A pilot MRI study of organ specific hemosiderosis and functional correlation in Chinese patients with myelodysplasia and aplastic anemia with raised ferritin levels, Hematological Oncology, 2008, 26, 4

    Direct Link:

    • Abstract
    • PDF(94K)
    • References
19. 19
    André Tichelli, Smita Bhatia, Gérard Socié, Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation, British Journal of Haematology, 2008, 142, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(146K)
    • References
20. 20
    Sridhar Srinivasan, Charles A Schiffer, Current treatment options and strategies for myelodysplastic syndromes, Expert Opinion on Pharmacotherapy, 2008, 9, 10, 1667

    CrossRef